Table 3.

General characteristics of patients and pathological factors associated with the development of BCRL

		HR	95% CI	p-value
Infections		2.20	0.99–4.92	0.0540
Dyslipidaemia		0.22	0.05–0.95	0.0431
Body Mass Index (BMI) ≥ 25 kg/m2		1.09	0.65–1.84	0.7368
Estrogen receptor positive		13.0	2.31–72.8	0.0036
Progesterone receptor positive		0.44	0.15–1.28	0.1326
Hormone therapy		0.02	0.01–0.09	< 0.0001
Hormone therapy (time-dependent)		2.45	1.16–5.17	0.0187
Side	Extranodal extension
Right	Yes vs. No	3.38	1.53–7.47
Left	Yes vs. No	0.74	0.30–1.81
Side	Lymphovascular invasion
Right	Yes vs. No	1.41	0.74–2.70
Left	Yes vs. No	3.80	1.58–9.16

The hazard ratio (HR) of developing BCRL was calculated using Cox Proportional Hazard Model